We found a match
Your institution may have access to this item. Find your institution then sign in to continue.
- Title
Research Update.
- Abstract
The article reports research updates related to gene therapy. In August 2006, Sirna Therapeutics, Inc. has showed the results of the phase trial for Sirna-027, a therapeutic age-related macular degeneration, stating that the Sirna-027 were safe and well tolerated, and all 26 patients showed visual acuity stabilization eight weeks after a single injection. Meanwhile, a group of virologists has discovered that a specific human protein is essential for HIV to integrate into the human genome.
- Subjects
MEDICAL research; GENE therapy; CLINICAL trials; SIRNA Therapeutics Inc.; RETINAL degeneration treatment; HUMAN genome; RECOMBINANT proteins; HIV
- Publication
Molecular Therapy, 2006, Vol 14, Issue 5, p609
- ISSN
1525-0016
- Publication type
Article
- DOI
10.1016/j.ymthe.2006.09.003